李嘉誠基金會再資助1,000萬支持公私營醫院協作 捐500萬補助6間安老院抗疫支出
李嘉誠基金會公佈最新支援抗疫措施,包括再增1,000萬元支持公私營醫院協作,兩間港安醫院將響應加入,並會緊急撥款500萬元補助6間護理安老院抗疫支出。
基金會指,自2月19日宣佈支援私家醫院接收公立醫院轉介病人後,各區公立醫院已陸續轉介不同病人至參與的私家醫院,目前資助的四類主要服務冠心病介入治療、部份癌症手術、癌症電療及分娩;新增參與計劃的私家醫院包括兩間港安醫院(荃灣及司徒拔道;基金會額外資助1,000萬元,以支援公立醫院非常緊急之轉介個案。另外,爲了協助院舍應付突如其來增加的開支和渡過疫境,基金會即時向6間院舍共捐贈500萬元,以助購置兩個月的防疫抗疫物資和應急之用。
基金會主席李嘉誠表示,惡疫當前,風雨同路,必能度脫苦厄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.